UNICK FIX-A-FORM AND PRINTERS | VISTA PHARMA | UNICK FIX-A-FORM AND PRINTERS/ VISTA PHARMA |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 27.1 | -7.8 | - | View Chart |
P/BV | x | 1.1 | 2.2 | 51.6% | View Chart |
Dividend Yield | % | 0.0 | 0.0 | - |
UNICK FIX-A-FORM AND PRINTERS VISTA PHARMA |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
UNICK FIX-A-FORM AND PRINTERS Mar-23 |
VISTA PHARMA Mar-23 |
UNICK FIX-A-FORM AND PRINTERS/ VISTA PHARMA |
5-Yr Chart Click to enlarge
|
||
High | Rs | 59 | 14 | 409.8% | |
Low | Rs | 32 | 7 | 483.9% | |
Sales per share (Unadj.) | Rs | 120.5 | 0.3 | 45,090.7% | |
Earnings per share (Unadj.) | Rs | 4.1 | -1.5 | -270.8% | |
Cash flow per share (Unadj.) | Rs | 11.2 | -1.3 | -835.4% | |
Dividends per share (Unadj.) | Rs | 0 | 0 | - | |
Avg Dividend yield | % | 0 | 0 | - | |
Book value per share (Unadj.) | Rs | 53.9 | 8.1 | 662.7% | |
Shares outstanding (eoy) | m | 5.49 | 37.56 | 14.6% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 0.4 | 39.1 | 1.0% | |
Avg P/E ratio | x | 11.1 | -6.9 | -159.7% | |
P/CF ratio (eoy) | x | 4.0 | -7.8 | -51.8% | |
Price / Book Value ratio | x | 0.8 | 1.3 | 65.3% | |
Dividend payout | % | 0 | 0 | - | |
Avg Mkt Cap | Rs m | 248 | 393 | 63.2% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 90 | 5 | 1,765.4% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 662 | 10 | 6,590.7% | |
Other income | Rs m | 5 | 4 | 128.1% | |
Total revenues | Rs m | 667 | 14 | 4,752.8% | |
Gross profit | Rs m | 88 | -44 | -197.4% | |
Depreciation | Rs m | 39 | 6 | 633.8% | |
Interest | Rs m | 24 | 12 | 196.2% | |
Profit before tax | Rs m | 30 | -59 | -50.9% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 7 | -2 | -349.1% | |
Profit after tax | Rs m | 22 | -57 | -39.6% | |
Gross profit margin | % | 13.3 | -442.7 | -3.0% | |
Effective tax rate | % | 25.0 | 3.6 | 685.5% | |
Net profit margin | % | 3.4 | -563.9 | -0.6% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 301 | 238 | 126.7% | |
Current liabilities | Rs m | 287 | 141 | 203.7% | |
Net working cap to sales | % | 2.1 | 963.0 | 0.2% | |
Current ratio | x | 1.0 | 1.7 | 62.2% | |
Inventory Days | Days | 4 | 207 | 1.9% | |
Debtors Days | Days | 72,349,839 | 40,902 | 176,885.1% | |
Net fixed assets | Rs m | 402 | 296 | 135.5% | |
Share capital | Rs m | 55 | 75 | 73.0% | |
"Free" reserves | Rs m | 241 | 230 | 104.6% | |
Net worth | Rs m | 296 | 306 | 96.9% | |
Long term debt | Rs m | 89 | 52 | 171.3% | |
Total assets | Rs m | 705 | 534 | 132.1% | |
Interest coverage | x | 2.3 | -3.8 | -58.7% | |
Debt to equity ratio | x | 0.3 | 0.2 | 176.8% | |
Sales to assets ratio | x | 0.9 | 0 | 4,987.8% | |
Return on assets | % | 6.6 | -8.3 | -78.6% | |
Return on equity | % | 7.6 | -18.5 | -40.9% | |
Return on capital | % | 14.0 | -13.1 | -107.0% | |
Exports to sales | % | 0 | 0 | - | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | NA | NA | - | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 0 | 0 | - | |
Fx outflow | Rs m | 0 | 0 | - | |
Net fx | Rs m | 0 | 0 | - |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 44 | -17 | -255.3% | |
From Investments | Rs m | -27 | -13 | 212.8% | |
From Financial Activity | Rs m | -16 | 31 | -52.3% | |
Net Cashflow | Rs m | 0 | 1 | 26.5% |
Indian Promoters | % | 71.6 | 19.9 | 359.3% | |
Foreign collaborators | % | 0.0 | 15.5 | - | |
Indian inst/Mut Fund | % | 0.5 | 0.0 | 1,125.0% | |
FIIs | % | 0.0 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 28.4 | 64.6 | 44.0% | |
Shareholders | 1,622 | 13,846 | 11.7% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare UNICK FIX-A-FORM AND PRINTERS With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | UNICK FIX-A-FORM AND PRINTERS | VISTA PHARMA | S&P BSE TECK |
---|---|---|---|
1-Day | -3.15% | 1.99% | -0.08% |
1-Month | 17.42% | 23.68% | -1.44% |
1-Year | 55.44% | 43.27% | 26.13% |
3-Year CAGR | 28.92% | 2.21% | 10.23% |
5-Year CAGR | 21.03% | -5.43% | 14.85% |
* Compound Annual Growth Rate
Here are more details on the UNICK FIX-A-FORM AND PRINTERS share price and the VISTA PHARMA share price.
Moving on to shareholding structures...
The promoters of UNICK FIX-A-FORM AND PRINTERS hold a 71.6% stake in the company. In case of VISTA PHARMA the stake stands at 35.4%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of UNICK FIX-A-FORM AND PRINTERS and the shareholding pattern of VISTA PHARMA.
Finally, a word on dividends...
In the most recent financial year, UNICK FIX-A-FORM AND PRINTERS paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.
VISTA PHARMA paid Rs 0.0, and its dividend payout ratio stood at -0.0%.
You may visit here to review the dividend history of UNICK FIX-A-FORM AND PRINTERS, and the dividend history of VISTA PHARMA.
For a sector overview, read our media sector report.
Asian stocks got off to a positive start on Monday ahead of the Federal Reserve's policy meeting later in the week.